Does the media prefer MBOT or MLSS?

In the previous week, Microbot Medical had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 3 mentions for Microbot Medical and 2 mentions for Milestone Scientific. Microbot Medical's average media sentiment score of 1.08 beat Milestone Scientific's score of 0.00 indicating that Microbot Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Milestone Scientific 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor MLSS or GUTS?

In the previous week, Fractyl Health had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 3 mentions for Fractyl Health and 2 mentions for Milestone Scientific. Fractyl Health's average media sentiment score of 0.88 beat Milestone Scientific's score of 0.00 indicating that Fractyl Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Milestone Scientific 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Fractyl Health 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MLSS or STIM?

In the previous week, Milestone Scientific and Milestone Scientific both had 2 articles in the media. Neuronetics' average media sentiment score of 0.63 beat Milestone Scientific's score of 0.00 indicating that Neuronetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Milestone Scientific 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Neuronetics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MLSS or SKIN?

In the previous week, Beauty Health had 8 more articles in the media than Milestone Scientific. MarketBeat recorded 10 mentions for Beauty Health and 2 mentions for Milestone Scientific. Beauty Health's average media sentiment score of 1.12 beat Milestone Scientific's score of 0.00 indicating that Beauty Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Milestone Scientific 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Beauty Health 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Milestone Scientific (MLSS) Competitors

$0.39 +0.01 (+3.30%)

Closing price 07/13/2026 04:00 PM Eastern

Extended Trading

$0.38 -0.01 (-3.68%)

As of 07:04 AM Eastern

Compare

MLSS vs. MBOT, GUTS, RCEL, STIM, and SKIN

Should you buy Milestone Scientific stock or one of its competitors? MarketBeat compares Milestone Scientific with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Milestone Scientific include Microbot Medical (MBOT), Fractyl Health (GUTS), Avita Medical (RCEL), Neuronetics (STIM), and Beauty Health (SKIN). These companies are all part of the "medical equipment" industry.

How does Milestone Scientific compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership and valuation.

Microbot Medical has a beta of 1.04, suggesting that its stock price is 4% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.05, suggesting that its stock price is 5% more volatile than the broader market.

In the previous week, Microbot Medical had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 3 mentions for Microbot Medical and 2 mentions for Milestone Scientific. Microbot Medical's average media sentiment score of 1.08 beat Milestone Scientific's score of 0.00 indicating that Microbot Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 4.7% of Microbot Medical shares are held by company insiders. Comparatively, 9.2% of Milestone Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Milestone Scientific has higher revenue and earnings than Microbot Medical. Milestone Scientific is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A
Milestone Scientific	$8.90M	3.92	-$6.93M	-$0.05	N/A

Microbot Medical has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Microbot Medical's return on equity of -21.84% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
Milestone Scientific	-52.01%	-60.26%	-40.23%

Microbot Medical currently has a consensus target price of $6.63, suggesting a potential upside of 252.39%. Milestone Scientific has a consensus target price of $1.00, suggesting a potential upside of 153.49%. Given Microbot Medical's higher possible upside, analysts plainly believe Microbot Medical is more favorable than Milestone Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Microbot Medical beats Milestone Scientific on 9 of the 16 factors compared between the two stocks.

How does Milestone Scientific compare to Fractyl Health?

Milestone Scientific (NYSE:MLSS) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

Milestone Scientific currently has a consensus price target of $1.00, indicating a potential upside of 153.49%. Fractyl Health has a consensus price target of $5.12, indicating a potential upside of 572.18%. Given Fractyl Health's higher possible upside, analysts plainly believe Fractyl Health is more favorable than Milestone Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Fractyl Health has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Fractyl Health	N/A	-4,053.15%	-96.41%

In the previous week, Fractyl Health had 1 more articles in the media than Milestone Scientific. MarketBeat recorded 3 mentions for Fractyl Health and 2 mentions for Milestone Scientific. Fractyl Health's average media sentiment score of 0.88 beat Milestone Scientific's score of 0.00 indicating that Fractyl Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fractyl Health	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Milestone Scientific has a beta of 1.05, suggesting that its stock price is 5% more volatile than the broader market. Comparatively, Fractyl Health has a beta of 2.29, suggesting that its stock price is 129% more volatile than the broader market.

Milestone Scientific has higher revenue and earnings than Fractyl Health. Milestone Scientific is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.90M	3.92	-$6.93M	-$0.05	N/A
Fractyl Health	$90K	1,342.71	-$140.95M	-$1.29	N/A

5.8% of Milestone Scientific shares are owned by institutional investors. 9.2% of Milestone Scientific shares are owned by company insiders. Comparatively, 8.5% of Fractyl Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Milestone Scientific and Fractyl Health tied by winning 8 of the 16 factors compared between the two stocks.

How does Milestone Scientific compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation, media sentiment and dividends.

Avita Medical has a beta of 1.86, meaning that its stock price is 86% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.05, meaning that its stock price is 5% more volatile than the broader market.

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by company insiders. Comparatively, 9.2% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Milestone Scientific has lower revenue, but higher earnings than Avita Medical. Milestone Scientific is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.70	-$48.59M	-$1.57	N/A
Milestone Scientific	$8.90M	3.92	-$6.93M	-$0.05	N/A

Milestone Scientific has a net margin of -52.01% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
Milestone Scientific	-52.01%	-60.26%	-40.23%

Avita Medical currently has a consensus target price of $7.25, suggesting a potential upside of 83.54%. Milestone Scientific has a consensus target price of $1.00, suggesting a potential upside of 153.49%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Milestone Scientific is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Milestone Scientific had 1 more articles in the media than Avita Medical. MarketBeat recorded 2 mentions for Milestone Scientific and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 1.87 beat Milestone Scientific's score of 0.00 indicating that Avita Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Avita Medical	Very Positive
Milestone Scientific	Neutral

Summary

Milestone Scientific beats Avita Medical on 9 of the 16 factors compared between the two stocks.

How does Milestone Scientific compare to Neuronetics?

Milestone Scientific (NYSE:MLSS) and Neuronetics (NASDAQ:STIM) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Neuronetics has a net margin of -24.48% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Neuronetics	-24.48%	-139.83%	-27.13%

Milestone Scientific has higher earnings, but lower revenue than Neuronetics. Milestone Scientific is trading at a lower price-to-earnings ratio than Neuronetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.90M	3.92	-$6.93M	-$0.05	N/A
Neuronetics	$149.16M	0.84	-$39M	-$0.54	N/A

In the previous week, Milestone Scientific and Milestone Scientific both had 2 articles in the media. Neuronetics' average media sentiment score of 0.63 beat Milestone Scientific's score of 0.00 indicating that Neuronetics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Neuronetics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Milestone Scientific presently has a consensus target price of $1.00, suggesting a potential upside of 153.49%. Neuronetics has a consensus target price of $3.00, suggesting a potential upside of 67.60%. Given Milestone Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Milestone Scientific is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

5.8% of Milestone Scientific shares are held by institutional investors. Comparatively, 53.6% of Neuronetics shares are held by institutional investors. 9.2% of Milestone Scientific shares are held by insiders. Comparatively, 8.4% of Neuronetics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Milestone Scientific has a beta of 1.05, meaning that its stock price is 5% more volatile than the broader market. Comparatively, Neuronetics has a beta of 1.06, meaning that its stock price is 6% more volatile than the broader market.

Summary

Milestone Scientific and Neuronetics tied by winning 7 of the 14 factors compared between the two stocks.

How does Milestone Scientific compare to Beauty Health?

Milestone Scientific (NYSE:MLSS) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, valuation, dividends, institutional ownership, earnings, risk and analyst recommendations.

Milestone Scientific has higher earnings, but lower revenue than Beauty Health. Milestone Scientific is trading at a lower price-to-earnings ratio than Beauty Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.90M	3.92	-$6.93M	-$0.05	N/A
Beauty Health	$300.80M	0.36	-$9.52M	-$0.17	N/A

Beauty Health has a net margin of -2.03% compared to Milestone Scientific's net margin of -52.01%. Beauty Health's return on equity of -9.38% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Beauty Health	-2.03%	-9.38%	-1.21%

Milestone Scientific has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market. Comparatively, Beauty Health has a beta of 1.08, indicating that its share price is 8% more volatile than the broader market.

Milestone Scientific presently has a consensus target price of $1.00, suggesting a potential upside of 153.49%. Beauty Health has a consensus target price of $2.02, suggesting a potential upside of 140.30%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Milestone Scientific is more favorable than Beauty Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Beauty Health	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

5.8% of Milestone Scientific shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 9.2% of Milestone Scientific shares are held by company insiders. Comparatively, 40.3% of Beauty Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Beauty Health had 8 more articles in the media than Milestone Scientific. MarketBeat recorded 10 mentions for Beauty Health and 2 mentions for Milestone Scientific. Beauty Health's average media sentiment score of 1.12 beat Milestone Scientific's score of 0.00 indicating that Beauty Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Beauty Health	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Beauty Health beats Milestone Scientific on 10 of the 15 factors compared between the two stocks.

Get Milestone Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MLSS vs. The Competition

Export

Metric	Milestone Scientific	Surgical appliances & supplies Industry	Medical Sector	NYSE Exchange
Market Cap	$34.89M	$23.51M	$7.05B	$23.46B
Dividend Yield	N/A	N/A	2.68%	4.02%
P/E Ratio	-5.63	13.59	27.11	31.08
Price / Sales	3.92	1.62	589.96	19.77
Price / Cash	N/A	12.80	29.22	18.64
Price / Book	3.59	1.53	10.74	4.77
Net Income	-$6.93M	-$3.92M	$3.58B	$1.06B
7 Day Performance	16.96%	3.66%	-2.11%	-0.23%
1 Month Performance	12.71%	3.00%	3.27%	-0.11%
1 Year Performance	-39.31%	-23.27%	26.31%	16.46%

Milestone Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MLSS Milestone Scientific	1.1347 of 5 stars	$0.39 +3.3%	$1.00 +153.5%	-40.8%	$34.89M	$8.90M	N/A	30
MBOT Microbot Medical	2.3727 of 5 stars	$1.89 +1.6%	$6.63 +250.5%	-28.2%	$126.94M	N/A	N/A	20	Positive News
GUTS Fractyl Health	4.2228 of 5 stars	$0.79 +0.2%	$5.12 +545.9%	-49.9%	$125.76M	N/A	N/A	102
RCEL Avita Medical	4.1404 of 5 stars	$4.06 -7.9%	$7.25 +78.6%	-30.7%	$124.96M	$72.35M	N/A	130	Positive News
STIM Neuronetics	3.1888 of 5 stars	$1.76 +6.0%	$3.00 +70.5%	-49.9%	$122.48M	$151.64M	N/A	180	Analyst Upgrade Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MLSS) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Milestone Scientific (MLSS) Competitors

MLSS vs. MBOT, GUTS, RCEL, STIM, and SKIN

How does Milestone Scientific compare to Microbot Medical?

Summary

How does Milestone Scientific compare to Fractyl Health?

Summary

How does Milestone Scientific compare to Avita Medical?

Summary

How does Milestone Scientific compare to Neuronetics?

Summary

How does Milestone Scientific compare to Beauty Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS vs. The Competition

Milestone Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Milestone Scientific (MLSS) Competitors

MLSS vs. MBOT, GUTS, RCEL, STIM, and SKIN

How does Milestone Scientific compare to Microbot Medical?

Which has more volatility and risk, MBOT or MLSS?

Does the media prefer MBOT or MLSS?

Do institutionals and insiders hold more shares of MBOT or MLSS?

Which has stronger earnings & valuation, MBOT or MLSS?

Is MBOT or MLSS more profitable?

Do analysts recommend MBOT or MLSS?

Summary

How does Milestone Scientific compare to Fractyl Health?

Do analysts rate MLSS or GUTS?

Is MLSS or GUTS more profitable?

Does the media favor MLSS or GUTS?

Which has more volatility and risk, MLSS or GUTS?

Which has higher valuation and earnings, MLSS or GUTS?

Do institutionals & insiders believe in MLSS or GUTS?

Summary

How does Milestone Scientific compare to Avita Medical?

Which has more risk & volatility, RCEL or MLSS?

Do institutionals and insiders hold more shares of RCEL or MLSS?

Which has better earnings & valuation, RCEL or MLSS?

Is RCEL or MLSS more profitable?

Do analysts rate RCEL or MLSS?

Does the media prefer RCEL or MLSS?

Summary

How does Milestone Scientific compare to Neuronetics?

Is MLSS or STIM more profitable?

Which has better earnings & valuation, MLSS or STIM?

Does the media favor MLSS or STIM?

Do analysts prefer MLSS or STIM?

Do insiders & institutionals believe in MLSS or STIM?

Which has more volatility & risk, MLSS or STIM?

Summary

How does Milestone Scientific compare to Beauty Health?

Which has better valuation and earnings, MLSS or SKIN?

Is MLSS or SKIN more profitable?

Which has more volatility & risk, MLSS or SKIN?

Do analysts recommend MLSS or SKIN?

Do institutionals and insiders hold more shares of MLSS or SKIN?

Does the media favor MLSS or SKIN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS vs. The Competition

Milestone Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools